If myasthenia gravis is well controlled, will it still recur?

Written by Shi De Quan

Neurology

Updated on May 12, 2025

00:00

00:00

Myasthenia gravis is difficult to control, and even when controlled, it is prone to relapse. The characteristic of myasthenia gravis includes alleviation after rest, and a pattern of alternating episodes and remissions.

Since there is no etiological treatment for myasthenia gravis at present, most medications are symptomatic treatments. However, some patients can find relief through plasmapheresis or immunoglobulin therapy, but most patients will experience relapses.

Therefore, myasthenia gravis is a disease prone to relapse, and its recurrence is not greatly influenced by how well it is controlled; it depends on the specific circumstances.

Other Voices

home-news-image

Written by Liu Hong Mei

Neurology

56sec

home-news-image

Can people with myasthenia gravis soak their feet?

Soaking in hot water can promote blood circulation, dilate blood vessels, improve local blood circulation in the lower limbs, promote metabolism, prevent thrombosis, and prevent muscle atrophy. In the early stages of myasthenia gravis, patients often experience limb discomfort, numbness, pain, blurred vision, and fatigue. In work and daily life, it is common to experience tiredness, memory loss, slow responses, and reluctance to be active. Soaking the feet can promote blood circulation and can improve local blood flow, which has a certain beneficial effect on myasthenia gravis. As the disease progresses, there is obvious fatigue and weakness in the skeletal muscles, especially after fatigue in the afternoon and evening, which is reduced in the morning or after rest.

home-news-image

Written by Zhang Hui

Neurology

1min 16sec

home-news-image

Is it dangerous to have a fever with myasthenia gravis?

Myasthenia gravis is a disease of the neuromuscular junction, essentially an autoimmune inflammatory response that causes generalized weakness and fatigue of the skeletal muscles, with symptoms that are less severe in the morning and worsen by the evening, and fluctuate over time. The weakness can be alleviated by rest. When patients with myasthenia gravis develop a fever, it is generally considered to be caused by an infection, perhaps a viral infection such as an upper respiratory tract infection, which can also induce fever. In such cases, the main treatment involves drinking plenty of water and consuming fresh vegetables and fruits. If necessary, some antiviral medications and antipyretics may be administered. If the fever is due to a bacterial infection, symptomatic treatment should be accompanied by the appropriate antibiotics. However, the choice of antibiotics must be made with caution. Patients with myasthenia gravis should not use aminoglycosides or fluoroquinolones, as these could exacerbate their condition. Penicillins or cephalosporins may be used instead. (Please consult a professional physician for specific medication guidance.)

home-news-image

Written by Tang Li Li

Neurology

1min 2sec

home-news-image

Myasthenia gravis should be seen in the Neurology department.

Patients with myasthenia gravis should consult the department of neurology, as myasthenia gravis is an immune-related neuromuscular junction disorder. Patients often exhibit pathological fatigue, skeletal muscle involvement, and unaffected smooth muscles. The most common type is ocular myasthenia, followed by mild and moderate generalized forms. Adult patients often have thymomas or thymic hyperplasia. Upon diagnosis of myasthenia gravis, it is essential to perform a comprehensive thymic CT scan. If thymic abnormalities are present, referral to thoracic surgery for treatment is needed. If there is no thymic disease, high-dose steroid pulse therapy may be considered. Additionally, it is crucial to determine whether the patient has other coexisting immune abnormalities, such as hyperthyroidism or connective tissue disease, and tailor the treatment accordingly.

home-news-image

Written by Zhang Hui

Neurology

1min 12sec

home-news-image

Myasthenia Gravis Test Items

Myasthenia gravis is a common neurological disease, primarily an autoimmune disorder. It typically results in symptoms that are worse in the evening and fluctuate throughout the day, mainly manifesting as limb weakness, double vision, swallowing difficulties, and speech impairments. In severe cases, it can even affect respiration, leading to weakness of the respiratory muscles and necessitating the assistance of a ventilator. The key examinations for myasthenia gravis include: Firstly, a chest CT scan. Many patients with myasthenia gravis have thymic hyperplasia or thymomas, making this scan crucial. Secondly, repetitive nerve stimulation electromyography. This test can detect amplitude decrement in response to stimulation, which is significant for diagnosing the disease. Thirdly, testing for specific antibodies related to myasthenia gravis, such as acetylcholine receptor antibodies. The presence of these antibodies is very important for diagnosis. Additionally, other tests such as erythrocyte sedimentation rate and thyroid function tests are also conducted.

home-news-image

Written by Zhang Hui

Neurology

55sec

home-news-image

Early symptoms of myasthenia gravis

Myasthenia gravis is an autoimmune disease of the nervous system that primarily affects the acetylcholine receptors on the postsynaptic membrane, causing muscle fatigue in patients. This can lead to general weakness throughout the body, double vision, and even progressive paralysis of the respiratory muscles, requiring active breathing assistance in severe cases. The early symptoms of myasthenia gravis mainly include: First, patients tend to fatigue easily, such as after exercise or labor, with a rapid decline in physical strength that only recovers after resting. Second, there may be ptosis, with patients unable to comfortably open their eyes, although this symptom can improve after resting or sleeping. As myasthenia gravis progresses into its later stages, there is a marked increase in overall weakness, necessitating treatment in a neurology department.